-
Product Insights
NewFrataxin Mitochondrial – Drugs In Development, 2024
The Frataxin Mitochondrial pipeline drugs market research report outlays comprehensive information on the Frataxin Mitochondrial targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Friedreich Ataxia, and Cardiomyopathy. It also reviews key players involved in Frataxin Mitochondrial targeted therapeutics development with respective active and dormant or discontinued projects. Note:...
-
Product Insights
NewGlypican 3 – Drugs In Development, 2024
The Glypican 3 pipeline drugs market research report outlays comprehensive information on the Glypican 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Hepatocellular Carcinoma, and Solid Tumor. It also reviews key players involved in Glypican 3 targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewCholinesterase – Drugs In Development, 2024
The Cholinesterase pipeline drugs market research report outlays comprehensive information on the Cholinesterase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Cardiovascular which include indications of Alzheimer's Disease, Dementia, and Ischemic Stroke. It also reviews key players involved in Cholinesterase targeted therapeutics development with respective active and dormant or discontinued projects. Note: *...
-
Product Insights
NewExodeoxyribonuclease III – Drugs In Development, 2024
The Exodeoxyribonuclease III pipeline drugs market research report outlays comprehensive information on the Exodeoxyribonuclease III targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Unspecified Cancer. It also reviews key players involved in Exodeoxyribonuclease III targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewHIV Integrase – Drugs In Development, 2024
The HIV Integrase pipeline drugs market research report outlays comprehensive information on the HIV Integrase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Human Immunodeficiency Virus (HIV) Infections (AIDS), and Tuberculosis. It also reviews key players involved in HIV Integrase targeted therapeutics development with respective active and dormant or discontinued projects....
-
Product Insights
NewAngiopoietin 2 – Drugs In Development, 2024
The Angiopoietin 2 pipeline drugs market research report outlays comprehensive information on the Angiopoietin 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology, Oncology, and Undisclosed which include indications of Wet (Neovascular / Exudative) Macular Degeneration, Diabetic Macular Edema, Oncology, Metastatic Melanoma, and Unspecified. It also reviews key players involved in Angiopoietin 2 targeted therapeutics development...
-
Product Insights
NewRibonucleoside Diphosphate Reductase Large Subunit – Drugs In Development, 2024
The Ribonucleoside Diphosphate Reductase Large Subunit pipeline drugs market research report outlays comprehensive information on the Ribonucleoside Diphosphate Reductase Large Subunit targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Pancreatic Cancer, and Solid Tumor. It also reviews key players involved in Ribonucleoside Diphosphate Reductase Large Subunit targeted therapeutics development with respective active...
-
Product Insights
NewCalreticulin – Drugs In Development, 2024
The Calreticulin pipeline drugs market research report outlays comprehensive information on the Calreticulin targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Ophthalmology, Hematological Disorders, and Gastrointestinal which include indications of Myeloproliferative Disorders, Essential Thrombocythemia, Choroidal Neovascularization, Hematological Disorders, and Inflammatory Bowel Disease. It also reviews key players involved in Calreticulin targeted therapeutics development with respective active...
-
Product Insights
NewPlasmodium falciparum Merozoite Surface Protein 1 – Drugs In Development, 2024
The Plasmodium falciparum Merozoite Surface Protein 1 pipeline drugs market research report outlays comprehensive information on the Plasmodium falciparum Merozoite Surface Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Malaria. It also reviews key players involved in Plasmodium falciparum Merozoite Surface Protein 1 targeted therapeutics development with respective active...
-
Product Insights
NewHepatitis B Virus DNA Polymerase – Drugs In Development, 2024
The Hepatitis B Virus DNA Polymerase pipeline drugs market research report outlays comprehensive information on the Hepatitis B Virus DNA Polymerase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, and Undisclosed which include indications of Hepatitis B, and Unspecified. It also reviews key players involved in Hepatitis B Virus DNA Polymerase targeted therapeutics development with...